secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2025-03-25T23:59:59+00:00
Accession:  0001641172-25-000506
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech Q4 net revenue up 49% to $26.3M; net loss widens to $1.7M
------------------------------------------------------------------------

- Q4 net revenue $26.3M (+49% YoY); full year $86.7M (+33% YoY).
- Q4 net loss $1.7M vs $0.3M loss prior year; full year net loss $9.9M vs $4.4M.
- Adjusted EBITDA Q4 $0.9M (vs $0.4M); full year $2.7M (vs $0.1M).
- Sanara Surgical Q4 net income $0.9M; Tissue Health Plus segment loss $2.6M on platform buildout.
- Exclusive license & distribution deal with BMI for OsStic bone void filler; term loan amended for additional borrowings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000164117225000506/0001641172-25-000506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000164117225000506/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-000506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer